
Regis (RGS) | Stock Overview & Key Data
Regis Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $465.40 on October 28, 2019
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Regis RGS | 47.67M Micro-cap | 0.10% | -7.81% | -9.95% | -17.44% | -18.42% | -16.05% | -36.32% | -89.34% |
Rollins ROL | 27.78B Large-cap | 0.10% | 4.58% | 0.89% | 14.14% | 25.85% | 15.56% | 68.04% | 57.96% |
Service SCI | 11.31B Large-cap | 1.11% | 6.05% | 4.52% | 3.54% | 5.48% | 5.54% | 27.78% | 76.61% |
Medifast MED | 155.52M Micro-cap | 7.28% | 2.61% | 1.00% | -0.98% | -18.16% | -29.18% | -89.47% | -91.51% |
Yy Group Holding YYGH | 75.88M Micro-cap | -10.00% | -31.52% | 18.13% | 6.18% | 8.00% | 155.41% | -35.71% | -35.71% |
Medirom Healthcare MRM | 14.22M Micro-cap | -17.81% | 30.43% | 127.85% | 104.55% | 78.22% | -69.74% | -73.66% | -87.71% |
Ownership & Short Interest
Regis Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Regis would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is RGS's 52-week high and low?
- In the last 52 weeks, Regis reached a high of $29.28 (on September 27, 2024) and a low of $15.00 (on April 9, 2025).
- What is the market cap and P/E ratio for RGS?
- Curious about Regis's size and valuation? Its market capitalization stands at 47.67M. When it comes to valuation, the P/E ratio (trailing twelve months) is 0.52, and the forward P/E (looking ahead) is -7.41.
- Does RGS pay dividends? If so, what's the yield?
- As for dividends, Regis isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Regis's main competitors or similar companies to consider before investing?
When looking at Regis, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Rollins
ROL27.78B Consumer Cyclical Personal Services 15.56% 68.04% Service
SCI11.31B Consumer Cyclical Personal Services 5.54% 27.78% Medifast
MED155.52M Consumer Cyclical Personal Services -29.18% -89.47% Yy Group Holding
YYGH75.88M Consumer Cyclical Personal Services 155.41% -35.71% Medirom Healthcare
MRM14.22M Consumer Cyclical Personal Services -69.74% -73.66% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Regis Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Regis's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 548.07%, the Debt to Equity ratio from the most recent quarter is 535.95, and its Gross Profit Margin stands at 36.96%.
- What is the recent revenue and earnings growth for RGS?
- Looking at Regis's growth, its revenue over the trailing twelve months (TTM) was $199M. Compared to the same quarter last year (YoY), quarterly revenue grew by 15.80%, and quarterly earnings saw a YoY growth of 15.81%.
- How much of RGS stock is held by insiders and institutions?
- Wondering who owns Regis stock? Company insiders (like executives and directors) hold about 14.05% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 30.96%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.